Cargando…
Azole Compounds as Inhibitors of Candida albicans: QSAR Modelling
Candida albicans is a pathogenic opportunistic yeast found in the human gut flora. It may also live outside of the human body, causing diseases ranging from minor to deadly. Candida albicans begins as a budding yeast that can become hyphae in response to a variety of environmental or biological trig...
Autores principales: | Gheidari, Davood, Mehrdad, Morteza, Ghahremani, Mahboubeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667819/ https://www.ncbi.nlm.nih.gov/pubmed/34912782 http://dx.doi.org/10.3389/fchem.2021.774416 |
Ejemplares similares
-
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017) -
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
por: Yuan, Rui, et al.
Publicado: (2021) -
Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013) -
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis
por: Badali, Hamid, et al.
Publicado: (2022) -
Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
por: El-Ganiny, Amira M., et al.
Publicado: (2022)